Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2001
05/23/2001CN1296491A 2-(purin-9-YL)-tetrahydrofuran-3, 4-diol derivatives
05/23/2001CN1296489A Phosphonic diester derivatives
05/23/2001CN1296488A Bicycle hydroxamic acid derivatives
05/23/2001CN1296486A Glucocorticoid-selective anti-inflammatory agents
05/23/2001CN1296485A Substituted indolealkanoic acids
05/23/2001CN1296483A Febrifugine and isofebrifugine and processes for the preparation of both
05/23/2001CN1296481A (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
05/23/2001CN1296478A Histamine H3 receptor ligands
05/23/2001CN1296474A Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors
05/23/2001CN1296471A Substituted 2-phenyl-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system and pharmaceutical compositions containing them
05/23/2001CN1296413A Composition and method for modulating cytokine release in response to genotoxic agents
05/23/2001CN1296412A Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
05/23/2001CN1296411A Remedies for cardiac dilastolit disorders
05/23/2001CN1296410A Methods for inhibiting MRP1
05/23/2001CN1296409A Treatment of panic attacks
05/23/2001CN1296408A Methods for inhibiting MRP1
05/23/2001CN1296407A Device for the transdermal delivery of dicolfenac
05/23/2001CN1296406A Pharmaceutial compositions
05/23/2001CN1296011A Purine L-nucleoside, its analogue and use thereof
05/23/2001CN1296010A Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same
05/23/2001CN1296008A Dioxacyclopentedien-6-(5aH)-one compound, its preparation process and medicinal composition
05/23/2001CN1295858A Process for preparation of medicine of treat ulcerative colitis
05/23/2001CN1295848A Powder medicine for treating born and scald
05/23/2001CN1295845A Traditional Chinese medicine for treating burn and scald and preparation process thereof
05/23/2001CN1295841A Adhesive plaster for osteophytosis
05/23/2001CN1295835A Compound medicine for treating hyperhydrochloria
05/23/2001CN1295834A Medicinal composition for treating proctoptoma
05/23/2001CN1066155C Purified heparin fractions, method for obtaining them and pharmaceutical composition containing them
05/23/2001CN1066151C Prodrugs of pacolitaxel derivatives
05/23/2001CN1066150C Bridged indole as matrix metalloprotease inhibitors
05/23/2001CN1066149C Diazepino-indoles as phosphodiesterase IV inhibitors
05/23/2001CN1066147C Purine derivatives and processes for their preparation
05/23/2001CN1066146C Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof
05/23/2001CN1066145C N-substituted 3-azabicyclo (3,2,0) heptane derivatives and preparing method and use thereof
05/23/2001CN1066142C 喹唑啉衍生物 Quinazoline derivatives
05/23/2001CN1066138C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones
05/23/2001CN1066135C Synthesized excitatory amino acid
05/23/2001CN1066058C Oral liquid for treating lamb scours and preparation process thereof
05/23/2001CN1066055C Productive method for extracting flavonoid compound extract or powder from bamboo leaf
05/23/2001CN1066042C Hair regrowth liniment and its preparation method
05/23/2001CN1066041C Anti-inflammatory, antipruritic and prickly-heat-expelling skin liquid
05/22/2001US6236946 Nuclear receptor ligands and ligand binding domains
05/22/2001US6235923 Retinoids and cell differentiation
05/22/2001US6235922 Processes and intermediates for preparing benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
05/22/2001US6235907 Intermediates useful in making mappicine and related compounds
05/22/2001US6235903 Method for preparing sulfanyl-type endothelin receptor antagonists
05/22/2001US6235897 Separation of cephalosporin isomers
05/22/2001US6235891 Glucocorticoid receptor agonist and decreased PP5
05/22/2001US6235879 Apoptosis modulators that interact with the Huntington's disease gene
05/22/2001US6235796 Use of fluorocarbons for the prevention of surgical adhesions
05/22/2001US6235795 Natural mixture composed of higher primary aliphatic alcohols obtained from bee wax for the treatment of gastric and duodenal ulcers that also present antiinflamatory activity
05/22/2001US6235793 Use of agonists of adrenergic β-3 receptors for preparing wound-healing medicines
05/22/2001US6235792 Phosphate salt of isopropyl-methyl- [2-(3-n-propoxyphenoxy)ethyl]amine
05/22/2001US6235791 Using cis n-cyclohexyl-n-ethyl(3-(3-chloro-cyclohexylphenyl)allyl)amine
05/22/2001US6235788 Method for treating pre-malignant basal and squamous cell lesions of the epithelium
05/22/2001US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis
05/22/2001US6235785 Methods for identifying and treating resistant tumors
05/22/2001US6235784 Medicament and therapeutical method for treating idiopathic asthenozoospermia
05/22/2001US6235783 Male fertility with antioxidants and/or polyunsaturated fatty acids
05/22/2001US6235782 Method for treating a patient with neoplasia by treatment with a platinum coordination complex
05/22/2001US6235780 ω-cycloalkyl-prostaglandin E1 derivatives
05/22/2001US6235779 Use of cis-Δ4 analogs of prostaglandins as ocular hypotensives
05/22/2001US6235778 Anticoagulants
05/22/2001US6235776 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
05/22/2001US6235774 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration
05/22/2001US6235773 Administering skin thickening agent
05/22/2001US6235772 Lipoic acid analogs
05/22/2001US6235771 Anilide derivative, production and use thereof
05/22/2001US6235770 Anticholesterol agents
05/22/2001US6235769 Methods of preventing and treating neurological disorders with compounds that modulate the function of the C-RET receptor protein tyrosine kinase
05/22/2001US6235768 Osteoporosis; rheumatic disorders; antitumor agents
05/22/2001US6235767 Methods to treat arterial plaque
05/22/2001US6235766 1-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical preparations comprising them
05/22/2001US6235765 Benzimidazole derivatives
05/22/2001US6235764 Isothiazole derivatives useful as anticancer agents
05/22/2001US6235760 Treatment for CNS injuries
05/22/2001US6235759 Benign prostatic hyperplasia; hypotensive agents
05/22/2001US6235758 Indole derivatives as 5-HT receptor antagonist
05/22/2001US6235757 Substituted heterocycles
05/22/2001US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide
05/22/2001US6235755 FSH mimetics for the treatment of infertility
05/22/2001US6235754 Using 1,4-diaryl-(2-fluoro- or 2,3-difluoro-)-2-butene
05/22/2001US6235753 Tumor necrosis factor; autoimmune diseases; antiallergens
05/22/2001US6235752 Isoquinolinamine and phthalazinamine derivatives which interact with CRF receptors
05/22/2001US6235751 Quinolizine carboxylic acid derivatives
05/22/2001US6235750 Nitric oxide synthase inhibitor
05/22/2001US6235747 6-phenyl-pyridin-2-ylamine derivatives
05/22/2001US6235745 Use of 5HT3, antagonists for promoting intestinal lavage
05/22/2001US6235742 5-substituted pyrazolo[4,3-D]pyrimidin-7-ones
05/22/2001US6235740 Autoimmune diseases; antiproliferation agents
05/22/2001US6235739 5-phenyl-3-pyridazinone derivatives and drug composition containing the same
05/22/2001US6235738 Brain disorders; antiischemic agents
05/22/2001US6235737 Reduction of hair growth
05/22/2001US6235735 Aftertreatment of radiation therapy
05/22/2001US6235734 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
05/22/2001US6235733 Aids therapy
05/22/2001US6235732 Neurokinin antagonists
05/22/2001US6235730 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same
05/22/2001US6235729 Uses of phospholipase C inhibitors
05/22/2001US6235727 Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and use